Benjamin Shaker - Mar 15, 2023 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Markets Officer
Signature
/s/ Steve Meetre, as Attorney-in-Fact
Stock symbol
AGL
Transactions as of
Mar 15, 2023
Transactions value $
-$1,948,204
Form type
4
Date filed
3/17/2023, 04:55 PM
Previous filing
Feb 16, 2023
Next filing
Apr 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Options Exercise $70K +70K +273.17% $1.00* 95.6K Mar 15, 2023 Direct F1
transaction AGL Common Stock Options Exercise $25K +25K +26.14% $1.00* 121K Mar 15, 2023 Direct F1
transaction AGL Common Stock Sale -$833K -35K -29.02% $23.81 85.6K Mar 15, 2023 Direct F1, F2
transaction AGL Common Stock Sale -$595K -25K -29.2% $23.80 60.6K Mar 15, 2023 Direct F1, F3, F4
transaction AGL Common Stock Options Exercise $25K +25K +41.24% $1.00* 85.6K Mar 16, 2023 Direct F1
transaction AGL Common Stock Sale -$112K -4.59K -5.36% $24.36 81K Mar 16, 2023 Direct F1, F3, F5
transaction AGL Common Stock Sale -$252K -9.83K -12.13% $25.65 71.2K Mar 16, 2023 Direct F1, F3, F6
transaction AGL Common Stock Sale -$276K -10.6K -14.86% $26.08 60.6K Mar 16, 2023 Direct F1, F3, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Right to buy) Options Exercise $0 -70K -21.39% $0.00 257K Mar 15, 2023 Common Stock 70K $1.00 Direct F8
transaction AGL Options (Right to buy) Options Exercise $0 -25K -48.22% $0.00 26.9K Mar 15, 2023 Common Stock 25K $1.00 Direct F9
transaction AGL Options (Right to buy) Options Exercise $0 -25K -93.11% $0.00 1.85K Mar 16, 2023 Common Stock 25K $1.00 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.50 to $24.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.52 to $24.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.98 to $24.975, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $24.98 to $25.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $25.98 to $26.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F8 These options were granted on December 30, 2016, and became fully vested as of January 12, 2021.
F9 These options were granted on April 27, 2017, and became fully vested as of January 12, 2021.

Remarks:

Exhibit List: Ex.24 - Power of Attorney